Trial Search
Current Search Criteria:
A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC
PHASE1This study is designed to determine the efficacy and safety of durvalumab a...
Status
Active Not Recruiting
Location
Research Site
Start Date
2018-12-27
Trial ID
NCT03819465
Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma
PHASE2MARIO-3 is a Phase 2 multi-arm combination cohort study designed to evaluat...
Status
Unknown
Location
Ironwood Cancer and Research Center
Start Date
2019-12-17
Trial ID
NCT03961698
Treatments Being Tested
A Study to Evaluate the Safety and Efficacy of Ipatasertib in Combination With Atezolizumab and Paclitaxel or Nab-Paclitaxel in Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer
PHASE1This is a study consisting of four cohorts in this setting. In Cohort 1, th...
Status
Completed
Location
Pacific Shores Medical Group
Start Date
2018-02-13
Trial ID
NCT03800836
Treatments Being Tested
A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.
PHASE1The purpose of this study is to learn about the safety and effects of the s...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2024-12-10
Trial ID
NCT06704724
An Umbrella-designed Prospective Multicenter Randomized Open-label Superiority Trial Evaluating Multi-biomarker-guided Precision Therapy for First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma
PHASE2This is a prospective, multicenter, randomized, open-label, umbrella superi...
Status
Not Yet Recruiting
Location
Sub-i
Start Date
2026-07-07
Trial ID
NCT07709533
Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid Tumors
PHASE1Background: LMB-100 is a man-made protein designed to kill cancer cells. L...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2016-08-03
Trial ID
NCT02810418
Treatments Being Tested
An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC.
PHASE2This is a Phase II, open-label, randomized controlled umbrella trial evalua...
Status
Unknown
Location
Cancer Hospital Affiliated to Fudan University
Start Date
2020-07-28
Trial ID
NCT04395989
Treatments Being Tested
A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.
PHASE1The purpose of this study is to learn about the safety and effects of the s...
Status
Active Not Recruiting
Location
Highlands Oncology Group, PA
Start Date
2024-06-27
Trial ID
NCT06447662
AB122 Platform Study
PHASE1This is a phase 1, non-randomized open-label, multicenter platform study de...
Status
Recruiting
Location
A site selected by Taiho Pharmaceutical Co., Ltd.
Start Date
2021-06-01
Trial ID
NCT04999761
Mesothelin-Targeted Immunotoxin LMB-100 in People With Malignant Mesothelioma
PHASE1Background: LMB-100 is a man-made protein. It is attracted to the mesothel...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2016-07-27
Trial ID
NCT02798536
Treatments Being Tested